⌘+K

Pulse Explore Clubs Researchers Journals

Home Clubs Explore

May 14, 2007Journal of Applied Toxicology

Human variability in hepatic and renal elimination: implications for risk assessment

View Full Paper

Ask AI

Bookmark

Share

Authors

JDJ.L.C.M. DorneEuropean Food Safety Authority

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

J.L.C.M. Dorne (2007) studied this question.

synapsesocial.com/papers/6a179ef9aeefdf6d9c12c5a6 https://doi.org/10.1002/jat.1255

View Full Paper

Ask AI

Bookmark

Share

Also Consider

Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context:

1Demographic factors influencing cyclosporine pharmacokinetic parameters in patients with uremia: Racial differences in bioavailability1992 · 122 citations
2A Probabilistic Approach for Deriving Acceptable Human Intake Limits and Human Health Risks from Toxicological Studies: General Framework1998 · 154 citations
3An Approach for the Quantitative Consideration of Genetic Polymorphism Data in Chemical Risk Assessment: Examples with Warfarin and Parathion2002 · 54 citations
4Factors affecting the absolute bioavailability of nifedipine.1995 · 133 citations